IFNA1 and COVID-19: Specifically, its beneficial role is presumed by the ample evidence that severe COVID-19 is characterized by diminished or suppressed IFN production and activity, inborn errors associated with the IFN signaling cascade or the presence of autoantibodies against IFNα or IFNγ [10,11,12,13,14,15,16,17,18,19].